Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones affect brain injury differently in males and females.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride effectively treats male hair loss, improving growth and density.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hairless protein can both repress and activate vitamin D receptor functions, affecting gene regulation.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Smad4 is important for healthy hair follicles because it helps produce a protein needed for hair to stick together and grow.

The normal human prostate does not significantly affect blood DHT levels.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.